Schonfeld Strategic Advisors’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-234,294
| Closed | -$549K | – | 3101 |
|
|
2022
Q3 | $549K | Buy |
234,294
+79,566
| +51% | +$186K | ﹤0.01% | 1661 |
|
|
2022
Q2 | $469K | Buy |
154,728
+13,638
| +10% | +$41.3K | ﹤0.01% | 1327 |
|
|
2022
Q1 | $958K | Sell |
141,090
-13,100
| -8% | -$88.9K | 0.01% | 960 |
|
|
2021
Q4 | $1.29M | Buy |
154,190
+37,406
| +32% | +$312K | 0.01% | 761 |
|
|
2021
Q3 | $867K | Sell |
116,784
-13,228
| -10% | -$98.2K | 0.01% | 941 |
|
|
2021
Q2 | $885K | Sell |
130,012
-78,800
| -38% | -$536K | 0.01% | 931 |
|
|
2021
Q1 | $2.14M | Buy |
+208,812
| New | +$2.14M | 0.03% | 615 |
|
|
2018
Q2 | – | Sell |
-22,280
| Closed | -$498K | – | 1015 |
|
|
2018
Q1 | $498K | Buy |
+22,280
| New | +$498K | 0.04% | 478 |
|